On January 15, Gelonghui reported that Beijing Leadman Biochemistry (300289.SZ) stated on the investor interaction platform that the company currently has not applied for any registration certificates for products related to Monkeypox Virus Testing. As for the specific review timeline of patents related to Monkeypox Virus Testing, please refer to the information released by the relevant departments, and the company will continue to closely monitor related developments.
Clear
All
Quotes
News
Learn
Help
All
HK
US
CN
SG
AU
JP
All
News
Announcements
Reports
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
-
The market is buzzing! DeepSeek ignites a buying frenzy in Hong Kong stocks, and Hong Kong Banks are running low on Cash.
Massive buying! A large amount of funds is flowing into Hong Kong Technology Stocks, Bank of America: Long-term investors in China Stocks are returning.
WEIMOB INC surged over 10% in the final trading hours, becoming one of the first AI tool service providers for WeChat small stores.
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
利德曼(300289.SZ):目前没有申请猴痘病毒检测的相关产品的注册证书
Beijing Leadman Biochemistry (300289.SZ): Currently, there are no registered certificates for products related to Monkeypox Virus Testing.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Like
Views 207
Write a comment
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report